Anti-inflammatory · Joint Health · Ingredient Monograph

BioSOLVE Curcumin®

Curcuma longa L. · 20% curcuminoids · water-dispersible powder

BioSOLVE Curcumin®: water-dispersible 20% curcuminoid. 8.9× bioavailability in a human study; Nutrafoods 2022 clinical publication. Distributed by Biontera.

BioSOLVE Curcumin®

The known limitation of standard curcumin extracts is oral bioavailability below 1%: the molecule is water-insoluble, poorly absorbed in the gut, and rapidly metabolised and eliminated. BioSOLVE Curcumin® is a water-dispersible curcumin powder produced on a patented platform technology engineered to overcome exactly this limit.

In an open-label, randomised, two-period cross-over human bioavailability study, BioSOLVE Curcumin® (500 mg) demonstrated 8.9× relative bioavailability versus a standard 95% curcumin extract (1000 mg) ; at half the dose.[1] Clinical efficacy and safety data were published in the peer-reviewed journal Nutrafoods (2022).[2]

Joint-health and mobility-comfort formulations — capsules, tablets, sachets
Antioxidant and healthy-ageing combinations
Functional beverages and liquid dosage forms enabled by water dispersibility
Polyphenol component in sports-recovery formulations
Minimum-effective-dose strategy: lower label dose than standard curcumin
8.9×
Relative bioavailability (human study)
20%
Curcuminoid standardisation
Clinical and Technical Evidence

Curcumin's biological activity — modulation of multiple transcription factors and signalling pathways, notably NF-κB — is extensively documented. The practical barrier is pharmacokinetic: solubility, intestinal absorption, rapid hepatic conjugation and systemic elimination. The BioSOLVE® platform embeds curcuminoids in a water-dispersible matrix, markedly increasing dissolution rate and plasma exposure (AUC, Cmax).

In a 12-week randomised, double-blind, placebo-controlled study, 24 volunteers with rheumatoid arthritis received 250 mg BioSOLVE Curcumin® twice daily; pain, stiffness and physical function assessed by ACR20, VAS and WOMAC improved significantly versus placebo with a favourable safety profile.[2] At the 90-day assessment, the change in VAS pain score was reported as 74.96% in the test group versus 8.33% under placebo.[3]

Human BioavailabilityZeus Hygia data file · Rev.

Open-label cross-over bioavailability study

At half the dose, BioSOLVE Curcumin® showed multi-fold superiority in plasma curcuminoid AUC and Cmax over the standard extract. Randomised, 2-treatment × 2-period cross-over, fasting · n = 10 healthy adults · 500 mg (T) vs 1000 mg standard 95% curcumin (R) · 48-hour sampling

8.9×
Relative bioavailability
16 time points
Sampling
Superior exposure at half dose
Dose advantage
Clinical & ToxicologyNutrafoods · 2022

Efficacy and safety in rheumatoid arthritis

Significant improvement versus placebo in pain, stiffness and physical function; no safety signal throughout the study. Randomised, double-blind, placebo-controlled · n = 24 · 250 mg × 2/day · 12 weeks

−74.96% (test)
VAS pain change
−8.33%
Placebo arm
ACR20 · VAS · WOMAC
Scales
Identity and Technical Dossier

Every shipment can be delivered with a 12-item technical documentation file on request:

Lot-based Certificate of Analysis (CoA)
GMP certificate
Product specification
Analytical methods
MSDS safety data sheet
TDS technical data sheet
Stability and shelf-life data
Manufacturing flow chart
Certificate of origin
Allergen and GMO-free statement
BSE/TSE statement
Halal and Kosher certificates (on request)
Frequently Asked Questions
How does BioSOLVE Curcumin® differ from a standard curcumin extract? +

Standard 95% curcumin extract is water-insoluble with oral bioavailability below 1%. BioSOLVE Curcumin® is a 20% curcuminoid ingredient made water-dispersible through a patented platform technology; in a human cross-over study it showed 8.9× relative bioavailability at half the dose.

Which dosage forms can it be used in? +

Capsules, tablets, sachets and chewables ; and, thanks to its water dispersibility, functional beverages and syrup-type liquid formulations.

How do I access the clinical data file? +

The Nutrafoods 2022 publication and the human bioavailability study summary are shared in full text after a mutual NDA. Use the contact page for samples and the technical dossier.

How does supply work in Türkiye? +

Biontera is Zeus Hygia's exclusive distributor for Türkiye. Shipment within 24–48 hours from our Ministry of Health-licensed warehouse in Başkent OSB, Ankara, with lot-based CoA and full technical documentation.

References
  1. [1]BioSOLVE Curcumin® Human Oral Bioavailability Study — open label, randomized, two-period cross-over, n=10.Zeus Hygia Lifesciences, study summary (Rev.)
  2. [2]Jeyakodi S, et al. BioSOLVE Curcumin®: efficacy and safety in rheumatoid arthritis complications — randomized, double-blind, placebo-controlled study.Nutrafoods, 2022
  3. [3]Improvement in VAS pain score, % change in 90 days: test 74.96% vs placebo 8.33%.Zeus Hygia technical file
First Step

Is this active right for your product? Let's assess it together.

Send your request for samples, lot-based CoA and the clinical data file; our technical team replies within 24 hours.